Trial intelligence / Profile preview

BMAC Post-Meniscectomy for Osteoarthritis

NCT02582489Active, not recruiting

Sponsor
Rush University Medical Center
Start
Dec 2017
Primary completion
Nov 2026
Modality
Stem Cell Therapies
Countries
1
01

Overview

Randomised, double-blind trial in osteoarthritis (OA) comparing Meniscectomy with BMAC with Meniscectomy with Placebo (2 arms). Primary endpoint: International Knee Documentation Committee Score at 1 year. Started Dec 2017; status: active, not recruiting.

02

Drugs

autologous bone marrow cell concentrate
03

Conditions

osteoarthritis (OA)

Beyond the preview

Go deeper on NCT02582489.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02582489.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call